Literature DB >> 6138370

The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.

J P McEvoy.   

Abstract

The clinician using neuroleptic drugs for the treatment of psychotic patients must face a number of questions regarding whether and how to use anticholinergic drugs when extrapyramidal side effects appear. This article explores some of these questions, suggests how they might best be answered, reviews the studies which address the questions, and notes some of the deficiencies in the available data base. Strategies for anticholinergic drug use, given the limited information available, are offered.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6138370

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


  10 in total

1.  Quetiapine (Seroquel) shows a pattern of behavioral effects similar to the atypical antipsychotics clozapine and olanzapine: studies with tremulous jaw movements in rats.

Authors:  A Betz; K Ishiwari; A Wisniecki; N Huyn; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

2.  Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.

Authors:  Anders Fink-Jensen; Lene S Schmidt; Ditte Dencker; Christina Schülein; Jürgen Wess; Gitta Wörtwein; David P D Woldbye
Journal:  Eur J Pharmacol       Date:  2011-01-24       Impact factor: 4.432

3.  Managing anticholinergic side effects.

Authors:  Joseph A Lieberman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

Review 4.  Clinically significant interactions of psychotropic agents with antipsychotic drugs.

Authors:  M C Meyer; R J Baldessarini; D C Goff; F Centorrino
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

5.  Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.

Authors:  R E Steinpreis; P Baskin; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Interaction study between remoxipride and biperiden.

Authors:  W Yisak; L Farde; C von Bahr; L B Nilsson; G Fredriksson; S Ogenstad
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.

Authors:  Adrienne J Betz; Peter J McLaughlin; Melissa Burgos; Suzanne M Weber; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2007-06-27       Impact factor: 4.530

8.  Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats.

Authors:  Anna Wisniecki; Merce Correa; Maria N Arizzi; Keitha Ishiwari; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

9.  Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.

Authors:  Lyndsey E Collins-Praino; Nicholas E Paul; Kristen L Rychalsky; James R Hinman; James J Chrobak; Patrick B Senatus; John D Salamone
Journal:  Front Syst Neurosci       Date:  2011-07-04

10.  Subthalamic and Cortical Local Field Potentials Associated with Pilocarpine-Induced Oral Tremor in the Rat.

Authors:  Lauren L Long; Samantha J Podurgiel; Aileen F Haque; Emily L Errante; James J Chrobak; John D Salamone
Journal:  Front Behav Neurosci       Date:  2016-06-17       Impact factor: 3.558
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.